第一線抗結核薬の薬剤遺伝学: 最新情報
Alessandra Manca1, Andrea Calcagno2, Antonio D'Avolio1
1Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Amedeo di Savoia Hospital, Turin, Italy; and.
Therapeutic drug monitoring
|September 3, 2025
まとめ
薬剤遺伝学は,イソニアジドやリファンピシンなどの第一線抗生物質に対する個人の反応に影響を与え,結核の治療に影響を与える. 遺伝子の多様性を理解することで 結核の治療薬の個性化により より良い結果が得られます
科学分野:
- 薬剤遺伝学と精密医療
- 感染症の治療薬
背景:
- 結核 (TB) の治療には,イソニアジド,リファンピシン (RF),エタンブトール (EMB),ピラジナミドを含む長期の抗生物質投与が必要である.
- 薬の代謝と反応の個々の変動は,結核治療の有効性と毒性に大きな影響を及ぼします.
- 薬剤遺伝学は,薬剤の薬理学に影響を与える遺伝的多形性を考慮することによって,結核治療を最適化するための経路を提供します.
研究 の 目的:
- 抗結核第一線抗生物質の有効性および毒性における薬剤遺伝子の役割を検討する.
- 主要な結核薬の薬動学に影響を与える遺伝的変異を調べる
- 遺伝子プロファイルに基づいて 個別化された結核治療のための潜在的な戦略を特定する.
主な方法:
- PubMed,Scopus,Web of Science,Cochrane Libraryの総合的な文献検索を行いました
- 2014年12月から2024年12月に出版された英語の研究に焦点を当てます.
- 薬剤の生物利用性とヒトの代謝に影響を与える遺伝的変異を調査する研究を含む.
主要な成果:
- イソニアジドの効能と毒性は,N- アセチルトランスファーゼ2 (NAT2) 遺伝子ポリモルフィズムと関連している.
- CYP2E1,GSTM1,MnSODの遺伝的変異がイソニアジド誘発性肝毒性に影響する.
- リファンピシン (RF) の薬物動態は,SLCO1B1,ABCB1,PXR,CAR,CES1,CES2の変異によって影響を受け,吸収,代謝,クリアランスに影響する.
- エタムボトール (EMB) の生物利用性は,特にTB/ HIV共感染において,CYP1A2変異によって著しく低下することがあります.
- 他の遺伝子変異 (ABCB1,OATP1B1,PXR,VDR,CYP24A1,CYP27B1) は,EMB濃度および有効性を調節する可能性があります.
結論:
- 薬物遺伝学を 結核の臨床実践に組み込むことで 治療の有効性を高め 毒性を最小限に抑えることができます
- 遺伝子プロファイルに基づく 個別化された投与戦略は 結核の薬物治療の最適化に不可欠です
- 結核の管理に薬剤遺伝学を日常的に導入するためにさらなる研究と臨床検証が必要であり,精密医療への道を開きます.
関連する概念動画
Pulmonary Tuberculosis V
237
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
237
Nonlinear Pharmacokinetics: Role of Transporters
91
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
91
Nonlinear Pharmacokinetics: Causes of Nonlinearity
338
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
338
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
293
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
293
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Factors Affecting Drug Biotransformation: Biological
231
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
231


